Loading, Please Wait...
RENO, Nev., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions, developer and manufacturer of the ROSINBOMB brand of industry leading consumer and commercial rosin presses and technology, announced the successful completion of their merger with Licont Corp (LNTP:OTC). The combined company will be renamed Maverick Technology Solutions and is trading on the OTC Markets under the symbol “LNTP”. The company will file for a symbol change. Maverick Technology Solutions develops and markets rosin extract presses under the ROSINBOMB brand to consumers and professionals for use in creating essential oils and extracts.
“We are excited about this next stage of development for our business and technology” stated Maverick CEO Fred Angelopoulos. “We believe this merger will help accelerate our mission of providing more medical and recreational consumers and professionals the ability to produce organic, solventless, safe extracts.” Added Company Founder and President Ryan Mayer.
Following the reverse merger, Maverick Technology Solutions, under the ROSINBOMB brand, will continue to produce and advance its product line including the consumer targeted ‘Rosinbomb Rocket’ press along with the commercially targeted ‘Rosinbomb M-50’ press and related accessories.
ABOUT MAVERICK TECHNOLOGY SOLUTIONS:
Maverick Technology Solutions has over three years of operating history of developing and producing the ROSINBOMB line of rosin presses for extracting natural organic concentrates. Founded as a family company with deep roots in creating press technology for the organic fruit and vegetable juice market, ROSINBOMB presses use no chemicals or solvents, and instead use techniques optimized to allow the user the ability to easily produce clean, safe, naturally extracted organic concentrates. Additional information can be found at: http://www.rosinbomb.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995.
Statements in this press release that are not strictly historical are “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve a high degree of risk and uncertainty, are predictions only and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to differences include the uncertainty regarding viability and market acceptance of the company’s products and services.